Tracing Dissemination of Melanoma Cells in Healthy Tissues
NCT02854124 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 226
Last updated 2025-11-20
Summary
The objective of this project is to evaluate the presence of melanoma quiescent or initiating clonal cells in peritumoral healthy tissue displaying the same molecular signature than those of the tumor/metastasis and to correlate this presence to the prognostic value.
Conditions
Interventions
- PROCEDURE
-
Melanoma and peritumoral skin excision
Surgical retrieval of the primary tumor and safety retrieval of the surrounding normal peritumoral skin and sentinel lymph node
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
collaborator OTHER_GOV -
URC-CIC Paris Descartes Necker Cochin
collaborator OTHER -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Romain Fontaine, PhD · INSERM - UMRS 938
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-12
- Primary Completion
- 2021-11-12
- Completion
- 2021-11-12
Countries
- France
Study Locations
More Related Trials
-
Study of Molecular Mechanisms Implicated in the Pathogenesis of Melanoma. Role of Exosomes
NCT02310451 ·Status: COMPLETED ·Phase: NA
-
A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma
NCT00001296 ·Status: COMPLETED ·Phase: PHASE3
-
DermTech's Non-Invasive Pigmented Lesion Assay to Detect and Track Lesions for Suspected Melanoma and to Determine Outcomes for up to 2 Years
NCT04563949 ·Status: COMPLETED
-
A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma
NCT00942162 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions
NCT04389112 ·Status: UNKNOWN ·Phase: NA
-
Characterisation of T Lymphocytes, NK Cells and Macrophages in Melanoma Patients
NCT01336270 ·Status: COMPLETED
-
A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France
NCT04550247 ·Status: ACTIVE_NOT_RECRUITING
-
Pre Transplantation Melanoma
NCT04217382 ·Status: COMPLETED
-
Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1
NCT05856565 ·Status: RECRUITING
-
Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma
NCT00896480 ·Status: COMPLETED ·Phase: PHASE2
-
High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
NCT00002763 ·Status: UNKNOWN ·Phase: PHASE3
-
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
NCT03199846 ·Status: COMPLETED
-
Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy
NCT02857374 ·Status: COMPLETED ·Phase: NA
-
Intratumoral Administration of L19IL2/L19TNF
NCT02076633 ·Status: COMPLETED ·Phase: PHASE2
-
Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery
NCT01886235 ·Status: COMPLETED ·Phase: NA
-
Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors
NCT04253080 ·Status: COMPLETED ·Phase: NA
-
Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690
NCT00937781 ·Status: COMPLETED
-
IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma
NCT01288963 ·Status: COMPLETED
-
Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma
NCT00897546 ·Status: COMPLETED
-
Investigation of the ROle of faT and inflAmmaTory Cells in mElanoma
NCT07293598 ·Status: NOT_YET_RECRUITING
-
Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma
NCT00002892 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients
NCT05615883 ·Status: COMPLETED ·Phase: NA
-
Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases
NCT04812470 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Families With Melanoma
NCT00445783 ·Status: UNKNOWN
-
Multicenter Selective Lymphadenectomy Trial (MSLT)
NCT00275496 ·Status: COMPLETED ·Phase: PHASE3